ENT Devices Market Size To Attain USD 37.2 Billion By 2032

The global ENT devices market reached USD 24.51 billion in 2023 and is expected to surpass USD 37.2 billion by 2032, growing at a CAGR of 4.74% from 2023 to 2032.

Key Points

North America led the global market with the highest market share of 36% in 2022.
Asia Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
By Product, the diagnostic ENT devices segment has held the largest market share of 31% in 2022.
By End User, the hospitals segment captured the biggest revenue share in 2022.

The factors which spur the growth of the market are raising geriatric population, increasing prevalence of ENT-related disorders, increasing penetration of minimally invasive ENT procedures. Moreover, technological advancement in the devices such as robot-assisted endoscopes systems leads to enhance the growth of the market.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1396

Moreover, ENT devices is registering it mark in the hospital, and clinics, as the increased in spending on healthcare facilities by government and private hospitals and rise in per capita are likely to augment the growth of the market.

The factors which augment the market are increasing prevalence of ear, nose, and throat related disorders. According to the data by World Health Organization in 2018, in United States, the incidence of hearing loss has increased from 11.5 million in 2008, to nearly 15 million in 2018.The ENT devices is expected to change the way the hospitals and clinics by introducing innovative methods and insights.

Report Highlights

Based on the product, the diagnostic devices segment accounted largest revenue share 29% in 2020. This can be attributed to increase in geriatric population along with rising prevalence of various ear, nose, and throat (ENT) disorders.
The hearing aids segment is expected to grow at the fastest rate over the forecast period due to increasing adoption of these devices, and technological advancements due to an increase in investment by market players on R&D.
Based on the end user, the hospitals segment was the leading segment in 2020. The rising prevalence of diseases coupled with the increased number of hospital admissions has significantly contributed towards the growth of this segment in the past few years. Moreover, rising investments for the development of better and improve healthcare infrastructure is boosting the growth of the hospitals especially in the developing regions.

Table of Contents

ENT Devices Market Scope

Report Highlights	Details
Market Size in 2023	USD 24.51Billion
Market Size by 2032	USD 37.2 Billion
Growth Rate from 2023 to 2032	CAGR of 4.74%
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Product, End User, Region

Regional Sanpshot

North America dominated the market and garnered 36% revenue share in 2020. This is attributed to the increased adoption rate of the latest technologies in the countries like US and Canada. The presence of high number of market players. The major factors which gain a major demand for the ENT devices are better healthcare infrastructure, favorable reimbursement policies, high cases of chronic sinusitis, and other ENT disorders.

Europe region accounted for the second-largest revenue share in 2020. The region has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels.

Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising government expenditure to develop strong healthcare infrastructure and government policies to attract FDIs is expected to play a significant role in the growth of the ENT devices market in the region. The presence of huge population and rising number of hospital admissions will foster the demand for the ENT devices in the Asia Pacific region, and will lead to the growth of the market during the forecast period.

The rising prevalence of ear, nose, and throat related disorders among the population will boost the demand for the ENT devices. Moreover, the rising adoption of minimally invasive ENT procedures and technological advancements are the driving factors for the growth of the market.

The high instrument costs and procedure associated with the and capital in the underdeveloped and developing nations may hamper the market growth during the forecast period.

The introduction of latest technologies such as artificial intelligence and machine learning may provide growth prospects to the market players in the upcoming future, and drive the market growth.

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
In September 2019, Cochlear Limited and GN Hearing collaborated with google for direct streaming android devices to hearing using Bluetooth Low Energy (BLE).
In September 2020, WS Audiology is a privately-owned manufacturer of hearing aids, launched of WIDEX MOMENT-the first generation of hearing aids that sound natural.
The various developmental strategies like acquisitions and mergers foster market growth and offers lucrative growth opportunities to the market players.